Organovo, a leader in bioprinting with life science research devices already on the market, has partnered with Autodesk, the maker of the ubiquitous AutoCAD drafting suite. They aim to create specialty printing software for Organovo’s bioprinters.
Organovo’s NovoGen MMX bioprinters have unique abilities and limitations, so software that will be used to design and print living tissue must take these details into account. We’re hoping that, much like the 3D printer revolution that’s supposedly about to commence, this announcement foreshadows a similar bioprinting revolution in the life sciences.
From the announcement:
“Autodesk is an excellent partner for Organovo in developing new software for 3D bioprinters,” said Keith Murphy, Chairman and Chief Executive Officer at Organovo. “This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3D tissues for production by Organovo.”
“Bioprinting has the potential to change the world,” said Jeff Kowalski, Senior Vice President and Chief Technology Officer at Autodesk. “It’s a blend of engineering, biology and 3D printing, which makes it a natural for Autodesk. I think working with Organovo to explore and evolve this emerging field will yield some fascinating and radical advances in medical research.”
More from Wired: Autodesk Developing CAD Software to Design, 3-D Print Living Tissue
Organovo press release: Organovo Partners With Autodesk Research to Develop 3D Bioprinting Software